Jones Financial Companies
ACHV icon

Jones Financial Companies’s Achieve Life Sciences ACHV Stock Holding History

Jones Financial Companies’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81K Sell
300
-200
-40% -$954 ﹤0.01% 4451
2026
Q1 		$1.32K Buy
500
+300
+150% +$1.33K ﹤0.01% 4272
2025
Q4 		$994 Buy
+200
New +$872 ﹤0.01% 4014

Other funds holding ACHV

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TPG GP A
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jones Financial Companies's ACHV Position: Q2 2026 in Review

Jones Financial Companies reduced its Achieve Life Sciences (ACHV) stake by 40% in Q2 2026, selling an estimated $954 and leaving 300 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #4451.

Jones Financial Companies first reported a position in ACHV in Q4 2025 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Jones Financial Companies held 300 shares of Achieve Life Sciences worth $1.81K as of Q2 2026.
  • Jones Financial Companies sold 200 Achieve Life Sciences shares in Q2 2026, an estimated $954.
  • Achieve Life Sciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4451 holding.
  • Jones Financial Companies first reported a position in Achieve Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.